International Congress of Virology, Sapporo, ASV Travel Request

描述(由申请人提供)： 摘要 Pi：Sawicki，Dorothea L项目：1R13AI091185-01标题：国际病毒学大会，札幌，ASV旅行申请登录号：3253449 = 注意：此摘要摘自应用程序，未经SRA校对。如果应用程序扫描过程有问题，提取的文本可能不正确或不完整。 = 美国病毒学学会希望通过这笔整笔赠款，为20名杰出的初级病毒学家参加2011年9月11日至16日举行的第XV届国际病毒学大会的旅费提供部分资助，每个奖项的费用为1,500美元，总额为30,000美元。三年一度的ICV将在日本札幌市举行，美国最好的初级病毒学家将代表美国，这是至关重要的。ICV是美国初级调查人员与国际公认的病毒学家直接会面和互动的独特机会，并通过全体会议、研讨会和海报会议了解所有病毒研究领域的最新发展，包括人类、动物、植物、昆虫和原核生物的病毒。将包括临床病毒学、艾滋病和丙型肝炎病毒以及新发现的逆转录病毒(慢性疲劳)、细小病毒和冠状病毒的当前问题。会议将涉及病毒进入和结构、病毒与细胞的相互作用、进化、免疫生物学、发病机制、病毒对宿主的防御、病毒复制和复制的宿主因素、新出现的病毒和病毒控制、诊断和疫苗等。研讨会和海报会议将讨论所有病毒家族及其复制和致病机制。ASV认为，在未来的工作中激励和帮助初级病毒学家的一个很好的方法是使他们能够直接与世界各地最好的病毒学家互动，这往往会产生独特的、持久的合作。如果NIH研究所/项目提供资金支持初级病毒学家前往XVth ICV，ASV总裁戈尔丁博士和当选总裁德莫迪将分别组织遴选委员会挑选将颁发旅行奖并从旅行奖中受益最大的申请者。成功的申请者需要一份令人满意的会后报告，详细说明他们的研究成果。我们的目标是为包括女性和少数族裔科学家在内的初级病毒学家提供部分资金，否则他们可能无法出席大会，目标是在未来几年内使美国的病毒学研究受益。病毒学研究的应用领域包括传染病、免疫学、肿瘤学、血液学、肺病学、心血管、胃肠病、神经学、眼科、儿童和慢性病、基础遗传学和生物技术。

DESCRIPTION (provided by applicant): Abstract PI: SAWICKI, DOROTHEA L Project: 1R13AI091185-01 Title: International Congress of Virology, Sapporo, ASV Travel Request Accession Number: 3253449 ================== NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE. ================== The American Society for Virology wishes to provide, through this block grant, partial support for the travel of 20 selected outstanding junior virologists to participate in the XVth International Congress of Virology (ICV) to be held September 11-16, 2011, at a level of $1,500 per award, for a $30,000 total. This triennial ICV will be in Sapporo, Japan, and it is essential for the U. S. to be represented by its best junior virologists. The ICV is a unique opportunity for U.S. junior investigators to meet and interact directly with internationally recognized expert virologists as well as learn in plenary sessions, workshops and poster sessions the most recent developments in all virus research areas, including viruses of humans, animals, plants, insects, and prokaryotes. Current problems in clinical virology, AIDS and HCV, and newly recognized retroviruses (chronic fatigue), parvoviruses and coronaviruses, will be included. Sessions will cover virus entry and structure, virus-cell interactions, evolution, immunobiology, pathogenesis, virus versus host defenses, virus replication and host factors for replication, emerging viruses and viral control, diagnostics and vaccines, among others. Workshop and poster sessions will address all virus families and their replication and pathogenesis. ASV considers one excellent way to stimulate and aid junior virologists in their future work is to enable them to interact directly with the best virologists world-wide, from which unique, long-lasting collaborations often result. If funds are provided by NIH institutes/programs to support travel of junior virologists to the XVth ICV, Drs. -Goldin and Dermody, President and President-elect of ASV, respectively, will organize the Selection Committee to choose applicants who will present and benefit most from the travel award. A satisfactory post-meeting report detailing the benefits to their research will be required of successful applicants. Our aim is to provide partial funding for junior virologists, including women and minority scientists, who might otherwise be unable to attend the Congress, with the goal of benefiting virological research in the U. S. A. for years to come. Virological research has applications for infectious, immunologic, neoplastic, hematologic, pulmonary, cardiovascular, GI, neurologic, ophthalmologic, childhood and chronic diseases, basic genetics and biotechnology.